USANA Health Sciences(US:USNA) ZACKS·2025-10-22 22:16分组1 - USANA Health Sciences reported a quarterly loss of $0.15 per share, matching the Zacks Consensus Estimate, compared to earnings of $0.56 per share a year ago [1] - The company posted revenues of $213.67 million for the quarter ended September 2025, slightly missing the Zacks Consensus Estimate by 0.1%, and showing an increase from $200.22 million year-over-year [2] - USANA Health shares have declined approximately 41.4% since the beginning of the year, contrasting with the S&P 500's gain of 14.5% [3] 分组2 - The earnings outlook for USANA Health is uncertain, with current consensus EPS estimates at $0.37 for the upcoming quarter and $1.70 for the current fiscal year [7] - The Medical - Drugs industry, to which USANA belongs, is currently ranked in the top 33% of over 250 Zacks industries, indicating a favorable industry outlook [8]